#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Stiff person syndrome Leiomyosarcoma Chorioretinitis Acute promyelocytic leukaemia Marginal zone lymphoma Acute hepatic failure Carcinoid tumour Alexander disease Ataxia telangiectasia Deafness neurosensory Arteriovenous malformation Follicular lymphoma stage III Ovarian cancer stage III Primary myelofibrosis Philadelphia chromosome positive More trials…

    Learn about Rare Diseases

    Wolfram syndrome – Basic Information Stevens-Johnson syndrome – Trials in Disease Glomerulonephritis rapidly progressive – Basic Information Lymphatic malformation – Treatment Splenic marginal zone lymphoma – Trials in Disease Short-bowel syndrome Rhabdomyosarcoma recurrent Congenital nephrogenic diabetes insipidus – Basic Information Tuberous sclerosis complex Malignant fibrous histiocytoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Motixafortide Dog Epithelia Trastuzumab Emtansine Linvoseltamab Trometamol Dydrogesterone Valbenazine Ditosylate Dostarlimab Ephedrine Hydrochloride Aliskiren Gfh925 Warfarin Progesterone, Micronised VALACICLOVIR HYDROCHLORIDE Gs-4182 Artemisia Vulgaris (312) SPY002 Tioguanine Arginine Hydrochloride Cefotaxime More therapies…

    Learn about Your Condition

    Stomatitis Univentricular heart Pericarditis Neoplasm malignant T-cell type acute leukaemia Pleomorphic leiomyosarcoma Testicular germ cell cancer Skin wrinkling Melanoma recurrent Coagulopathy Hepatoblastoma Fracture infection Carotid artery stenosis Piriformis syndrome End stage renal disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Intracranial aneurysm

  • Iodixanol in Cerebral Angiography for Patients with Unruptured Intracranial Aneurysms

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Iodixanol
    France

  • Study on Managing Risk Factors in Patients with Unruptured Brain Aneurysms Using Carbasalate Calcium and Intensive Blood Pressure Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Intracranial aneurysm
    Investigated Drugs:
    • Dipyridamole
    • Acetylsalicylic Acid
    Finland Germany The Netherlands

  • Study of acetylsalicylic acid to prevent stroke in patients undergoing brain aneurysm coiling procedure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Intracranial aneurysm
    Investigated Drugs:
    • Lactose Monohydrate
    • Acetylsalicylic Acid
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!